<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>4053</number>
    <updateDate>2025-05-27T14:12:59Z</updateDate>
    <updateDateIncludingText>2025-05-27T14:12:59Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2023-06-13</introducedDate>
    <congress>118</congress>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 169, Number 103 (Tuesday, June 13, 2023)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. KUSTER:H.R. 4053.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 1 of the United StatesConstitution, the Taxing and Spending Clause:``The Congress shall have Power To lay and collect Taxes,Duties, Imposts and Excises, to pay the Debts and provide forthe common Defense and general Welfare of the United States.. .''The single subject of this legislation is:This bill requires an evaluation of buprenorphine-naloxonecombination products in regards to their scheduling under theControlled Substances Act.[Page H2885]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2023-06-16T18:17:34Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2023-06-13T14:03:20Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2023-06-13T14:03:25Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2023-06-16</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-06-13</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-06-13</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-06-13</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-06-13</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>K000382</bioguideId>
        <fullName>Rep. Kuster, Ann M. [D-NH-2]</fullName>
        <firstName>Ann</firstName>
        <lastName>Kuster</lastName>
        <party>D</party>
        <state>NH</state>
        <middleName>M.</middleName>
        <district>2</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>C001103</bioguideId>
        <fullName>Rep. Carter, Earl L. "Buddy" [R-GA-1]</fullName>
        <firstName>Earl</firstName>
        <lastName>Carter</lastName>
        <party>R</party>
        <state>GA</state>
        <middleName>L. "Buddy"</middleName>
        <district>1</district>
        <sponsorshipDate>2023-06-13</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>T000469</bioguideId>
        <fullName>Rep. Tonko, Paul [D-NY-20]</fullName>
        <firstName>Paul</firstName>
        <lastName>Tonko</lastName>
        <party>D</party>
        <state>NY</state>
        <district>20</district>
        <sponsorshipDate>2023-06-20</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001221</bioguideId>
        <fullName>Rep. Molinaro, Marcus J. [R-NY-19]</fullName>
        <firstName>Marcus</firstName>
        <lastName>Molinaro</lastName>
        <party>R</party>
        <state>NY</state>
        <middleName>J.</middleName>
        <district>19</district>
        <sponsorshipDate>2024-01-03</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Drug trafficking and controlled substances</name>
          <updateDate>2024-02-12T15:45:17Z</updateDate>
        </item>
        <item>
          <name>Government studies and investigations</name>
          <updateDate>2024-02-12T15:45:17Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-07-21T18:45:17Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-06-13</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2024-06-21T21:40:10Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Studying Suboxone Act&amp;nbsp;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill requires the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) to reevaluate the scheduling of buprenorphine-naloxone combination products (e.g., suboxone) under the Controlled Substances Act.&amp;nbsp;These products are used to treat opioid addictions and are currently schedule III controlled substances. (A schedule III controlled substance is a drug, substance, or chemical that has less potential for abuse than a schedule I or II substance; that has a currently accepted medical use; and that has low or moderate risk of dependence if abused.)&lt;/p&gt;&lt;p&gt;Specifically, the bill requires HHS to review scientific and medical evaluations relating to these products and update its scheduling recommendations accordingly. The DEA must review the recommendations of HHS and make appropriate scheduling changes.&amp;nbsp;&lt;/p&gt;&lt;!--tinycomments|2.1|data:application/json;base64,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--&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Studying Suboxone Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Studying Suboxone Act</title>
        <updateDate>2024-07-24T15:21:27Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Studying Suboxone Act</title>
        <updateDate>2024-05-24T13:38:30Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To provide for the review of the scheduling under the Controlled Substances Act of buprenorphine-naloxone combination products, and for other purposes.</title>
        <updateDate>2024-03-18T20:59:54Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2023-06-13T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr4053ih/xml/BILLS-118hr4053ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-06-16</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
